Report copyright - In Vivo Antitumor Activity of SU11248, a Novel Tyrosine ... · plasma inhibitor levels. In target modulation studies in vivo, SU11248 selectively inhibited Flk-1/KDR (VEGF receptor
Please pass captcha verification before submit form